Markus Schaich received the M.D. degree from the Eberhard Karls University Tübingen, Germany, in 1995. Since 1995, he is working as a doctor and scientist at the University Hospital Carl Gustav Carus Dresden, Dresden, Germany. He received the scientific award of the Saxonian Society of Medicine in 1995 and the Best Abstract Award of the German Society of Hematology and Oncology in 2000. From 2001 to 2007, he specialized in internal medicine, hematology, oncology, gastroenterology, and palliative care. In 2003, he became a Consultant at the University Hospital Carl Gustav Carus Dresden, and, since 2008, he works as a Professor at the Dresden University of Technology, Dresden, Germany. Professor Schaich is the study coordinator and principal investigator of many treatment trails in hematology and oncology. His special interest lies in acute myeloid leukemia, where he is leading the multicenter treatment trials of the German Study Alliance Leukemia (SAL). He is a Member of the American Society of Hematology, the European Society of Oncology, the European Leukemia Net, and the German Society of Hematology and Oncology. Professor Schaich’s research interests include molecular evaluation of signal transduction and resistance mechanisms of tumors, as well as evaluation of prognostic factors and translational research in leukemia.
Biography Updated on 24 January 2011